Stable Istotope Labelled Vesencumab Biosimilar – Anti-Neuropilin-1/NRP1/VEGF165R extracellular domain mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Stable Istotope Labelled Vesencumab Biosimilar - Anti-Neuropilin-1/NRP1/VEGF165R extracellular domain mAb - Research Grade |
|---|---|
| Source | CAS 1205533-60-3 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >95% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue Ice |
| Delivery Time | 3-5 days if in stock; 5-8 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | MNRP1685A |
| Reference | PX-TA1266-SIL |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
| Format | Lyophilized |
| Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99% |
| Isotopic Enrichment | 99% |
| Stability | 1 year |
General information on Anti-Neuropilin-1/NRP1/VEGF165R extracellular domain [Homo sapiens] (Vesencumab) Monoclonal Antibody
Vesencumab is investigated for the treatment of Locally Advanced or Metastatic Solid Tumors.
Contact us
Send us a message from the form below
Reviews
There are no reviews yet.